iShares U.S. Pharmaceuticals ETF · $1.6B$18,602
IHEIHE vsARKGARKGARK Genomic Revolution ETF · $2.2B$6,586
$10,000 five years ago, dividends reinvested · they hold 4.6% in common
IHEMeasureARKG
Returns · dividends reinvested
+26.9%Year to dateJan 1 → Nov 3+70.9%
+42.7%1 yearTotal return+59.0%
+26.3%3 years · per year$10,000 became $20,159 · $22,262+30.6%
+13.2%5 years · per year$10,000 became $18,602 · $6,586−8.0%
Cost and income
0.37%Expense ratio$37 · $75 a year on $10k · lower is better0.75%
1.34%Trailing 12-mo yield$134 · $0 a year on $10k0.00%
Risk · past year
−9.7%Worst dropSmaller is better−27.5%
18.6%VolatilityLower is calmer45.8%
IHEARKG Winner of the row, in its colourEach row: the bigger of the two fills its side
5–3IHE wins
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns